Results 1 to 10 of about 11,489 (185)

Phosphaturic Mesenchymal Tumor: From Invisibility to Bedridden Morbidity. [PDF]

J ASEAN Fed Endocr Soc
Mukherjee R, Pattashanee SK, Singh BK, Krishna A, Soren S, Damle AN, Sharma MC, Seenu V.   +7 more
europepmc   +1 more source

Continuation of burosumab during pregnancy in a patient with X-linked hypophosphatemia. [PDF]

JCEM Case Rep
Suzuki A, Moriyama Y, Mizuno H, Nishizawa H.   +3 more
europepmc   +1 more source

Late diagnosis of SLC34A3-related hereditary hypophosphatemic osteomalacia following a low-energy proximal humeral 4-part fracture. [PDF]

JBMR Plus
Morimoto T.
europepmc   +1 more source

Klotho revisited: tubular heterogeneity reshapes mineral metabolism, aging, and CKD. [PDF]

Pflugers Arch
Pathare G.
europepmc   +1 more source

Symptomatic Ferric Carboxymaltose-Induced Hypophosphataemia: A Case Series of 11 Patients. [PDF]

EJHaem
Weerheim M, Korevaar H, Bizino M, Fortrie G, Vrolijk L, Koster T, Karim F.   +6 more
europepmc   +1 more source

Combined Targeted Drug Delivery Systems for Mineral Metabolism Disorders in Chronic Kidney Disease: A Narrative Review. [PDF]

Int J Nanomedicine
Li Y, Yang S, Xiong S, Wang X, Cheng K, Wang Y, Gong N.   +6 more
europepmc   +1 more source

Calcimimetics and CaSR signaling in CKD-MBD: bone-immune-vascular crosstalk and therapeutic potential. [PDF]

Front Immunol
Zheng CM, Hsu HC, Hou YC, Lu CL, Zheng JQ, Lu KC.   +5 more
europepmc   +1 more source

Effects of burosumab on macrophage polarization and TRPV1 expression in children with XLH. [PDF]

Endocr Connect
Di Paola A, Palumbo S, Argenziano L, Di Feo G, Aiello F, Di Domenico O, Cirillo G, Pietropaolo G, Marrapodi MM, Miraglia Del Giudice E, Rossi F, Grandone A.   +11 more
europepmc   +1 more source

FGF/FGFR signaling at the immune-stromal interface in autoimmune rheumatic diseases: from tissue remodeling to translational opportunities. [PDF]

Front Immunol
Zhong S, Meng X, Xiang Z, Qiu G, Sun S, Xie J, Xiao L.   +6 more
europepmc   +1 more source